Legal status · Australia
Is Monlunabant legal in Australia?
No. Monlunabant is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Monlunabant in Australia at a glance
| Classification | Investigational, not registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Evidence level | Preliminary (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Monlunabant profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
Monlunabant is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Monlunabant is
Novo Nordisk's oral peripherally acting CB1 blocker: 7.1 kg weight loss in 16 weeks in Phase 2a, but with dose-related anxiety, irritability and sleep problems that Phase 2b must resolve.
Monlunabant is an oral CB1 inverse agonist designed to act mainly outside the brain. 7 kg on placebo over 16 weeks.
Mechanism: Inverse agonism of peripheral cannabinoid CB1 receptors, reducing fat storage and improving metabolic signaling.
Regulatory history: Investigational; Phase 2b
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for Monlunabant at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Monlunabant in other countries
Frequently asked questions
Is Monlunabant legal in Australia?
No. Monlunabant is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Preliminary.
Can I buy Monlunabant in Australia?
No approved product exists to buy. In Australia Monlunabant is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Monlunabant TGA approved?
No. In Australia Monlunabant is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational; Phase 2b. Evidence level: Preliminary.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Monlunabant live on its compound profile.
Monlunabant profileThis page is general information about the regulatory status of Monlunabant in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.